FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases ...Middle East

SILVER SPRING, Md., Oct. 31, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases. Wezlana, like Stelara, is approved to treat the...

Hence then, the article about fda approves interchangeable biosimilar for multiple inflammatory diseases was published today ( Wednesday 01/11/2023 - 01:44 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases )

Also on site :

• My Daughter’s Friend Has a Crush on My Husband. It’s Making Us Both Deeply Uncomfortable.
• Maga’s biggest fear is coming true and Trump won’t survive it
• Tornado warning issued, and quickly cancelled, over Alhambra